Replaces everything after the enacting clause. Amends the Illinois Controlled Substances Act. Before issuing a prescription for a Schedule II, III, IV, or V controlled substance, a prescriber or his or her designee shall access the prescription monitoring program to determine compliance with the pharmacy and medication shopping provisions of the Act. Provides that within one year of the effective date of the bill, the Department shall adopt rules requiring all Electronic Health Records Systems to interface with the Prescription Monitoring Program application program on or before January 1, 2021 to ensure that all providers have access to specific patient records during the treatment of their patients. These rules shall also address the electronic integration of pharmacy records with the Prescription Monitoring Program to allow for faster transmission of the information required under the Act. Provides that the Department shall establish actions to be taken if a prescriber's Electronic Health Records System does not effectively interface with the Prescription Monitoring Program within the required timeline. Provides that the Department of Human Services, in consultation with the Advisory Committee, shall adopt rules allowing licensed prescribers or pharmacists who have registered to access the Prescription Monitoring Program to authorize a designee to consult the Prescription Monitoring Program on their behalf. The rules shall include reasonable parameters concerning a practitioner's authority to authorize a designee, and the eligibility of a person to be selected as a designee.
Senate Floor Amendment No. 2 Restores language of the law that when a person has been identified as having 3 or more prescribers or 3 or more pharmacies, or both, that do not utilize a common electronic file for controlled substances within the course of a continuous 30-day period, the Prescription Monitoring Program may (rather than shall) issue an unsolicited report to the prescribers, dispensers, and their designees informing them of the potential medication shopping.
Senate Floor Amendment No. 3 Replaces everything after the enacting clause. Amends the Illinois Controlled Substances Act. Reinserts the provisions of the bill as amended by Senate Amendments Nos. 1 and 2. Deletes provision that a prescriber who receives the report from the Prescription Monitoring Program concerning a person who has been identified as having 3 or more prescribers or 3 or more pharmacies, or both, either personally or through an agent at his or her place of practice, shall be prohibited from issuing a controlled substance to that same person unless the prescriber signs a statement on the prescription acknowledging receipt of the report. Deletes that if a pharmacy or pharmacist receives a prescription for a person he or she knows or should know to be the subject of the report, and the prescriber fails to provide the required acknowledgement, the pharmacy or pharmacist must contact the prescriber and obtain a signature on the acknowledgement before filling the prescription. Provides that if an unsolicited report is issued to a prescriber or prescribers, then the report must also be sent to the applicable dispensing pharmacy. Restores provision that nothing in this provision shall be construed to create a requirement that any prescriber, dispenser, or pharmacist report any patient activity, or prescribe or refuse to prescribe or dispense any medications. Also provides that a prescriber who prescribes a Schedule II, III, IV, or V controlled substance in the course of oncology treatment, a condition associated with oncology, or hospice care is exempt from having to check the Prescription Monitoring Program prior to prescribing the controlled substance.
Fiscal Note (Dept. of Public Health)
SB 1607 (S-AM 3) would have no fiscal impact to the Department of Public Health.